Clinical Trial Update: Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy [Phase 1]

View source ↗

Summary

Phase 1 pediatric trial update reports initial safety and dosing information for ixabepilone in children with relapsed or refractory solid tumors and leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Childhood Germ Cell Tumor
• Kidney Cancer
• Leukemia
• Liver Cancer
• Neuroblastoma
• Ovarian Cancer
• Sarcoma

Drugs mentioned

• Ixabepilone (ixabepilone)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 | Status: COMPLETED